# Evaluation of STARgraft-2 for Hemodialysis Access

> **NCT04783779** · NA · COMPLETED · sponsor: **Healionics Corporation** · enrollment: 24 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Implant of STARgraft-2 shunt in the upper arm and subsequent use for hemodialysis access

## Key facts

- **NCT ID:** NCT04783779
- **Lead sponsor:** Healionics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-16
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-10-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04783779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04783779, "Evaluation of STARgraft-2 for Hemodialysis Access". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04783779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*